CED Cannabis Science Digest: 3 CBD and Cannabinoid Product-Safety Signals Worth Watching
CBD and cannabinoid product signals: Three July 2026 papers sharpen how readers interpret CBD supplements, mislabeled CBD food products, and Delta-8 or Delta-9 cannabinoid detection. These are context and caution signals, not treatment-proof claims. The…
Review Explores How CB1 Signaling Connects Stress, Sleep and Eating Behavior
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepAnxietyMental HealthNeurologyResearchTHCSafety Why This Matters Clinicians managing patients with comorbid stress,…
Can Low-Dose CBD Feel Psychoactive? What the New Healthy-Volunteer Trial Actually Found
A 2026 randomized crossover study found that a 200 mg CBD pleasant drug effect was perceptible after oral administration in healthy occasional cannabis users. Lower doses did not produce this effect. This finding challenges the notion that low-dose CBD…
New Clinical Data Shows Promise for Cannabinoid Treatment in Advanced Dementia
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyResearchAgingMental HealthCBDTHCSafety Why This Matters Clinicians caring for dementia patients with agitation…
Medical cannabis initiative fails to qualify for Idaho’s general election ballot
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyHempCBDTHCSafetyResearchMental Health Why This Matters Idaho's failure to legalize medical cannabis means…
New Georgia Law Removes Barriers to Medical Cannabis
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainAnxietyMental HealthNeurologyCancerSafety Why This Matters Clinicians in Georgia can now more readily counsel…
First-of-its-kind trial finds dementia agitation eased by cannabis combination
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyResearchMental HealthAgingCBDTHCSafety Why This Matters Clinicians now have an evidence-based alternative to…
CBD for Pericarditis: What the New JAHA Trial Shows
CBD for recurrent pericarditis produced early pain and inflammation signals in a 27-person Phase II pilot trial. Most participants entering the extension remained recurrence-free while standard medications were tapered, but the study had no placebo group…
Spicy Roasted Brussels Sprouts With Cannabis Olive Oil
…
Pain Improved, Cravings Did Not: A Buprenorphine Study
Medical cannabis with buprenorphine was associated with modest improvements in pain, sleep, and quality of life over three months in adults with opioid use disorder and chronic pain. Opioid-positive urine screens declined numerically, but the change was…